CytomX Therapeutics (CTMX) Cash from Investing Activities (QoQ) (2015 - 2026)
CytomX Therapeutics (CTMX) Cash from Investing Activities (QoQ) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | CytomX Therapeutics | 582.34 Mn | 235.63 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,236.97% |
| Dec 31, 2025 | -3,384.51% |
| Sep 30, 2025 | 100.57% |
| Jun 30, 2025 | -349.58% |
| Mar 31, 2025 | 102.15% |
| Dec 31, 2024 | -16.69% |
| Sep 30, 2024 | -15.54% |
| Jun 30, 2024 | -52.07% |
| Mar 31, 2024 | 248.87% |
| Dec 31, 2023 | 129.96% |
| Sep 30, 2023 | -264.89% |
| Jun 30, 2023 | 117.76% |
| Mar 31, 2023 | -246.91% |
| Dec 31, 2022 | 24,445.85% |
| Sep 30, 2022 | 0.49% |
| Jun 30, 2022 | 44.02% |
| Mar 31, 2022 | -200.41% |
| Dec 31, 2021 | -102.52% |
| Sep 30, 2021 | 121.16% |
| Jun 30, 2021 | -177.97% |